Etanercept treatment in resistant spondyloarthropathy: Imaging, duration of effect an efficacy on reintroduction

Clinical and Experimental Rheumatology

Volumn 20, Issue 6 SUPPL. 28, 2002, Pages

  Marzo Ortega, Helena ^a   McGonagle, Dennis ^a   Emery, Paul ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Etanercept; Follow up; Imaging; Spondyloarthropathy

Indexed keywords

ANTIRHEUMATIC AGENT; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL RESPONSE MODIFIER; IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; FOLLOW UP; HUMAN; IRIDOCYCLITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPONDYLOARTHROPATHY; TREATMENT OUTCOME; DRUG RESISTANCE; RETREATMENT; TIME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; BIOLOGICAL RESPONSE MODIFIERS; DRUG RESISTANCE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; RECEPTORS, TUMOR NECROSIS FACTOR; RETREATMENT; SPONDYLARTHROPATHIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036401089     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. BRAUN J, BOLLOW M, REMLINGER G et al.: Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67.
2. ZINK A, BRAUN J, LISTING J, WOLLENHAUPT J: Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - Results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 2000; 27: 613-22.
3. VAN DEN BOSCH F, KRUITHOF E, BAETEN D et al.: Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloathropathy. Arthritis Rheum 2002; 46: 755-65.
4. BRAUN J, BRANDT J, LISTING J et al.: Treatment of active ankylosing spondylitis with infliximab: A randomised controlled multicentre trial. Lancet 2002; 359: 1187-93.
5. MARZO-ORTEGA H, MCGONAGLE D, O'CONNOR P, EMERY P: Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondyloarthropathy. Arthritis Rheum 2001; 44: 2112-7.
6. HELLIWELL PS, DOWARD L, WHALLEY D et al.: Psychometric and scaling properties of a new quality of life instrument specific to ankylosing spondylitis [abstract]. Arthritis Rheum 1999; 42 (Suppl. 9): S72.
7. JEVTIC V, WATT I, ROZMAN B, KOS-GOLJA M, DEMSAR F, JARH O: Distinctive radiological features of small hand joint in rheumatoid arthritis of the hand and seronegative spondyloarthropathy demonstrated by contrast enhanced (Gd-DTPA) magnetic resonance imaging. Skeletal Radiol 1995; 24: 351-5.
8. BRAUN B, BOLLOW M, EGGENS U, KONIG H, DISTLER A, SIEPER J: Use of dynamic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondyloarthropathy. Arthritis Rheum 1994; 37: 1039-45.
9. McGONAGLE D, GIBBON W, O'CONNOR P, GREEN M, PEASE C, EMERY P: Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondyloarthropathy. Arthritis Rheum 1998; 41: 694-700.
10. KRUITHOF E, VAN DEN BOSCH F, BAETEN D et al.: Repeated infusions of infliximab, a chimeric anti-TNF alpha monoclonal antibody, in patients with active spondyloarthropathy: A one year follow-up. Ann Rheum Dis 2002; 61: 207-12.
11. BRANDT J, HAIBEL H, SIEPER J, BRAUN J: Infliximab treatment of severe ankylosing spondylitis: One-year follow up. Arthritis Rheum 2001; 44: 2936-45.
12. BARTHEL HR: Rapid remission of treatment resistant ankylosing spondylitis with etanercept - A drug for refractory ankylosing spondylitis ? Arthritis Care & Res 2001; 45: 404.
13. GORMAN J, SACK KE, DAVIES JC: Etanercept in the treatment of ankylosing spondylitis: A randomized, double-blind, placebo controlled study. N Engl J Med 2002; 346: 1349-56.